The 2018 guidelines on caring for pregnant women with substance use disorder (SUD) and their babies from the Maine Department of Health and Human Services. The guidelines include clinical algorithms for screening for substance use during pregnancy and caring for
This guide focuses on creating coordinated, multi-system approaches to caring for pregnant women with opioid use disorder and their infants. It focuses on creating coordination between medical providers, addiction treatment and behavioral health providers, social service agencies including
Policymakers and clinicians in Ohio developed the Maternal Opiate Medical Support (MOMS) model of providing prenatal, obstetrical, and postpartum care for pregnant women with opioid use disorder. This guide includes a process to assess readiness to adopt the MOMS model and an
The 2018 SUPPORT Act passed by Congress directed the Centers for Medicare and Medicaid Services to create a exception to the institution for mental disease (IMD) exclusion for certain pregnant and postpartum women. The IMD exclusion forbids the expenditure of federal funding on services provided in facilities with
The 2018 SUPPORT Act passed by Congress directed the Centers for Medicare and Medicaid Services to create a new provider type in Medicaid of “residential pediatric recovery centers” (RPRCs) which treat infants with neonatal opiate withdrawal/neonatal abstinence syndrome. This letter provides guidance for states wishing to add RPRCs as provider types eligible for reimbursement through Medicaid.
This 2014 case study describes the Children and Recovery Mothers (CHARM) Collaboration which provides a model for integrated and collaborative care for pregnant women with opioid dependence and their babies. The case study focuses on how the CHARM initiative provides support to families at multiple points of intervention and
This toolkit includes informational resources for patients and providers addressing perinatal drug exposure and appropriate treatment of substance-exposed newborns. Guidance is offered for multiple substances including opioids, cocaine, ecstasy, methamphetamine, marijuana, anti-depressants, hallucinogens, and other substances (e.g., special K, kratom). The toolkit includes references and links to relevant resources. Funding Source: Northern Arizona Healthcare, Arizona Substance Abuse Task Force, Arizona Statewide Task Force on Preventing Prenatal Exposure to Alcohol and Other Drugs
This 2 page clinician guide provides an overview of how to assess and manage women with opioid use during pregnancy and how to provide optimal care to infants with neonatal opiate withdrawal/neonatal abstinence syndrome. Prepared by the Arizona Department of Health Services and the Arizona Statewide Task Force on Preventing Prenatal Exposure to Alcohol and Other Drugs. Funding Source: Arizona Department of Health Services, Arizona Statewide Task Force on Preventing Prenatal Exposure to Alcohol and Other Drugs
A 15-minute video of women talking about their experiences of getting help to address their opioid addiction and confront stigma during their pregnancies. Includes information about the importance of seeking treatment and support during pregnancy and in the postpartum period, and how these women worked with their providers to ensure a successful outcome for themselves and their
This is the website for Ohio’s Maternal Opiate Medical Supports (MOMS) collaborative which is working to improve maternal and baby health outcomes by providing obstetrical care and substance use disorder treatment treatment through a maternity care home model of care. The interactive website